Abstract
Preliminar results of our group indicated inhibition activity of violacein to Staphylococcus aureus including methicillin-resistant strains (MRSA). Continuing these analyses, the aim of this project is to evaluate the biological activity of violacein to S. aureus. For this, the antimicrobial activity will be evaluated on S. aureus strains with intermediate resistance to vancomycin (VISA s…